Tranexamic acid may stop dark spots before they start
NCT ID NCT05311033
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether tranexamic acid, a drug used to control bleeding, can prevent dark spots that often appear after skin inflammation. Ten healthy men at risk for hyperpigmentation will take the drug and have small blisters created on their skin to trigger the spots. Researchers will check if the drug reduces pigmentation and monitor for side effects over five weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tranexamic acid
What this could lead to
If it works, this could point toward a way to prevent dark spots after skin inflammation.
What could go wrong
This is a very small, early study with only 10 healthy men, so results may not apply to everyone. The treatment is tested on artificial blisters, not real-world skin conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN PIGMENTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nice - Hôpital de l'Archet
Nice, Alpes-maritimes, 06200, France